Your account is not claimed yet. You can sign up with ORCID to claim your account.

Franco Dallegri (F Dallegri)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 2

Top Topics

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Brain Metastases

Community Dwelling

Top Venues

Cancer immunology, immunotherapy : CII

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro

This page only lists publications with an associated author ORCID identifier.

Affiliation History

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro Nov 1o 2013

Italy

Director of Division of Medical Urgency

Publications

Aldo Bonaventura, Francesco Grossi, Federico Carbone, Alessandra Vecchiè, S Minetti, N Bardi, E Elia, A M Ansaldo, D Ferrara, E Rijavec, M G Dal Bello, Giovanni Rossi, F Biello, M Tagliamento, Angela Alama, Simona Coco, P Spallarossa, Franco Dallegri, Carlo Genova, Fabrizio Montecucco
Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (9) (2020)
Aldo Bonaventura, Francesco Grossi, Federico Carbone, Alessandra Vecchiè, Silvia Minetti, Nicholas Bardi, Edoardo Elia, Anna Maria Ansaldo, Daniele Ferrara, Erika Rijavec, Maria Giovanna Dal Bello, Giovanni Rossi, Federica Biello, Marco Tagliamento, Angela Alama, Simona Coco, Paolo Spallarossa, Franco Dallegri, Carlo Genova, Fabrizio Montecucco
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study. Cancer immunology, immunotherapy : CII 68 (8) (2019)